Subscribe Search Current Contents Home
Biofilms Online Logo
           an initiative of Montana State University Center for Biofilm Engineering
 
Current Contents
  Subscribe
NEWS
  Biofilm News
  Conferences
  Employment
  Media Reviews
  Patents
  Research Digest
VIEWS
  Biofilm Perspectives
EDUCATION
  Biofilm Primer
  Lab Exercises
  Short Courses
  Teachers
  Other Resources
about
current activities
masthead
our sponsors
disclaimer

Finely Tuned WspRs Help Bacteria Beat Body by Building Biofilm

Tetrameric assembly of the response regulator diguanylate cyclase WspR from Pseudomonas aeruginosa      Bacteria are particularly harmful to human health when they band together to form a biofilm—a sheet composed of many individual bacteria glued together—because this can allow them to escape from both antibiotics and the immune system of their host. It is thought that most chronic infections are caused by bacterial biofilms, and a paper published in this week’s PLoS Biology explores the signalling system that causes bacteria to team up in this way.
     Pseudomonas is the pathogen that forms biofilms in the lungs of people with cystic fibrosis. The new paper, from Holger Sondermann and colleagues, identifies a novel kind of control system for bacterial signalling. Bacteria form a biofilm when the concentration of a molecule called c-di-GMP gets above a certain threshold. Sondermann et al. have determined the structure of the enzyme that makes c-di-GMP. The enzyme is called WspR in Pseudomonas, and the way WspR is controlled in the cell is the focus of their paper.
     The authors determined the crystal structure of WspR and followed up with biochemical analysis of the enzyme. This work showed that WspR exists in an active form that produces c-di-GMP and is then bound by c-di-GMP and forced into an inactive form. The study therefore reveals a finely balanced equilibrium between the synthesis and degradation of this key player in biofilm formation.
     New approaches to controlling the behavior of bacteria responsible for chronic infections can be envisaged. Because the signalling molecules involved in biofilm formation, such as c-di-GMP, are uniquely found in bacteria, the authors hope that there is potential for new therapeutic treatments based on this work; if you interrupted this bacterial signalling it would have no negative effect on the human host but could be devastating for the bacteria.

###

Citation: De N, Pirruccello M, Krasteva PV, Bae N, Raghavan RV, et al. (2008) Phosphorylation-independent regulation of the diguanylate cyclase WspR. PLoS Biol 6(3): e67.doi:10.1371/journal.pbio.0060067

CONTACT:
Holger Sonderman
Cornell University
Department of Molecular Medicine
+1-607-253-3318
+1-607-253-3659 (fax)
hs293@cornell.edu

PLEASE MENTION THE OPEN-ACCESS JOURNAL PLoS BIOLOGY (www.plosbiology.org) AS THE SOURCE FOR THESE ARTICLES AND PROVIDE A LINK TO THE FREELY-AVAILABLE TEXT. PLEASE NOTE: THE CORRECT CITATION IS PLoS BIOLOGY, NOT PUBLIC LIBRARY OF SCIENCE BIOLOGY. THANK YOU.

All works published in PLoS Biology are open access. Everything is immediately available—to read, download, redistribute, include in databases, and otherwise use—without cost to anyone, anywhere, subject only to the condition that the original authorship and source are properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.

###

Public Release Date: 24 Mar 2008

Contact: Natalie Bouaravong
press@plos.org
415-568-3445
Public Library of Science


Email to a friend

sponsored by
donations from:

Industrial Associates
of the Center for
Biofilm Engineering
at Montana State
University-Bozeman

sponsor
our work




Copyright © 2002−2008
Published by:

Center for Biofilm Engineering
Contact Us Privacy  Policy BiofilmsONLINE.com
HOMEPAGE
Powered by InfoGears